TY - JOUR
T1 - Conquering the common bile duct
T2 - outcomes in minimally invasive transcystic common bile duct exploration versus ERCP
AU - Dejesus, Jana
AU - Horani, Keenan
AU - Brahmbhatt, Kush
AU - Mesa, Camila Franco
AU - Samreen, Sarah
AU - Moffett, Jennifer M.
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Introduction: Given the increasing interest for surgeons to reclaim the common bile duct in managing choledocholithiasis, there is a growing movement to perform common bile duct exploration (CBDE). Advantages of concomitant CBDE with cholecystectomy include fewer anesthetic events and decreased length of stay. As there is a paucity of literature evaluating the use of the robotic platform for CBDE, our study aims to compare intraoperative and post-operative outcomes between robotic-assisted one-stage and two-stage management of choledocholithiasis. Methods: A retrospective chart review was performed from May 1, 2022 to December 31, 2023, identifying patients with choledocholithiasis who underwent robot-assisted laparoscopic cholecystectomy and transcystic CBDE with choledochoscopy (one-stage management). Preoperative, intraoperative, and post-operative variables were compared to a control group of subjects with choledocholithiasis who underwent laparoscopic cholecystectomy with pre- or post-operative ERCP (two-stage management). Statistical analysis was performed using Chi-squared, Fisher’s exact, Student’s T, or Mann–Whitney test. Results: Fifty-three subjects who underwent one-stage management and 101 subjects who underwent two-stage management met inclusion criteria. Groups had similar demographics and medical history. Time to CBD clearance (45.2 h vs 47.0 h, p =.036), total length of stay (3.9 days vs 5.1 days, p =.007), fluoroscopy time (70.3 s vs 151.4 s, p <.001), and estimated radiation dose (23.0 mSv vs 40.3 mSv, p =.002) were significantly lower in the one-stage group compared to two-stage. Clearance rates, complication rates, and 30-day readmission rates were similar for both groups. Total length of stay and radiation exposure remained significantly lower on subanalysis comparing one-stage management to two-stage management with ERCP either before or after cholecystectomy. Conclusion: Robotic-assisted laparoscopic cholecystectomy with transcystic common bile duct exploration via choledochoscopy is a safe and feasible option in the management of choledocholithiasis. It offers a shorter time to duct clearance, shorter length of stay, and less radiation exposure when compared to two-stage management. Graphical Abstract: (Figure presented.)
AB - Introduction: Given the increasing interest for surgeons to reclaim the common bile duct in managing choledocholithiasis, there is a growing movement to perform common bile duct exploration (CBDE). Advantages of concomitant CBDE with cholecystectomy include fewer anesthetic events and decreased length of stay. As there is a paucity of literature evaluating the use of the robotic platform for CBDE, our study aims to compare intraoperative and post-operative outcomes between robotic-assisted one-stage and two-stage management of choledocholithiasis. Methods: A retrospective chart review was performed from May 1, 2022 to December 31, 2023, identifying patients with choledocholithiasis who underwent robot-assisted laparoscopic cholecystectomy and transcystic CBDE with choledochoscopy (one-stage management). Preoperative, intraoperative, and post-operative variables were compared to a control group of subjects with choledocholithiasis who underwent laparoscopic cholecystectomy with pre- or post-operative ERCP (two-stage management). Statistical analysis was performed using Chi-squared, Fisher’s exact, Student’s T, or Mann–Whitney test. Results: Fifty-three subjects who underwent one-stage management and 101 subjects who underwent two-stage management met inclusion criteria. Groups had similar demographics and medical history. Time to CBD clearance (45.2 h vs 47.0 h, p =.036), total length of stay (3.9 days vs 5.1 days, p =.007), fluoroscopy time (70.3 s vs 151.4 s, p <.001), and estimated radiation dose (23.0 mSv vs 40.3 mSv, p =.002) were significantly lower in the one-stage group compared to two-stage. Clearance rates, complication rates, and 30-day readmission rates were similar for both groups. Total length of stay and radiation exposure remained significantly lower on subanalysis comparing one-stage management to two-stage management with ERCP either before or after cholecystectomy. Conclusion: Robotic-assisted laparoscopic cholecystectomy with transcystic common bile duct exploration via choledochoscopy is a safe and feasible option in the management of choledocholithiasis. It offers a shorter time to duct clearance, shorter length of stay, and less radiation exposure when compared to two-stage management. Graphical Abstract: (Figure presented.)
KW - CBDE
KW - Choledocholithiasis
KW - Choledochoscopy
KW - ERCP
KW - Robot-assisted laparoscopic cholecystectomy
KW - Robotic surgery
KW - Transcystic common bile duct exploration
UR - http://www.scopus.com/inward/record.url?scp=85204386962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85204386962&partnerID=8YFLogxK
U2 - 10.1007/s00464-024-11228-5
DO - 10.1007/s00464-024-11228-5
M3 - Article
C2 - 39289226
AN - SCOPUS:85204386962
SN - 0930-2794
VL - 38
SP - 7552
EP - 7562
JO - Surgical Endoscopy
JF - Surgical Endoscopy
IS - 12
ER -